Literature DB >> 2436435

Thromboembolic complications in children with nephrotic syndrome. Risk and incidence.

P F Hoyer, S Gonda, M Barthels, H P Krohn, J Brodehl.   

Abstract

Coagulation studies were performed in 16 children with steroid responsive minimal change nephrotic syndrome in order to elucidate the incidence of thromboembolic complications. Fibrinogen and alpha 2-macroglobulin concentrations were inversely correlated with serum albumin concentrations, antithrombin III correlated positively (p less than 0.001). Factor VIII:R:AG concentration was elevated. Coagulation disturbances in children are not less severe than in adults with nephrotic syndrome. Combined scintigraphic pulmonary ventilation and perfusion studies were employed in 26 children to detect noninvasively events of pulmonary embolism, respectively their residual changes. The lung scintigraphic investigation demonstrated a pattern consistent with pulmonary embolism in 7 patients (27.9%), residual changes in 10 (38.5%) and normal findings in 9 (34.9%). The incidence of thromboembolic complications in children with severe nephrotic syndrome is as high as reported for adults. Pulmonary symptoms may well be due to pulmonary embolism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2436435     DOI: 10.1111/j.1651-2227.1986.tb10294.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  42 in total

1.  Recurrent haemolytic uraemic syndrome in a boy with focal and segmental glomerulosclerosis.

Authors:  A Bökenkamp; P F Hoyer; G Offner; U Helmchen; J Brodehl
Journal:  Eur J Pediatr       Date:  1992-10       Impact factor: 3.183

2.  Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome.

Authors:  Michelle N Rheault; Chang-Ching Wei; David S Hains; Wei Wang; Bryce A Kerlin; William E Smoyer
Journal:  Pediatr Nephrol       Date:  2013-09-14       Impact factor: 3.714

3.  Recurrent renal vein thrombosis and renal failure associated with antithrombin-III deficiency.

Authors:  D Ellis
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

4.  Low protein Z levels in children with nephrotic syndrome.

Authors:  Ozan Ozkaya; Kenan Bek; Tunc Fişgin; Yuksel Aliyazicioğlu; Sevinc Sultansuyu; Yonca Açikgöz; Davut Albayrak; Kemal Baysal
Journal:  Pediatr Nephrol       Date:  2006-06-30       Impact factor: 3.714

5.  Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy.

Authors:  Yoshitsugu Kaku; Yasufumi Ohtsuka; Yasuhiro Komatsu; Toshiyuki Ohta; Takuhito Nagai; Hiroshi Kaito; Shuji Kondo; Yohei Ikezumi; Seiji Tanaka; Shinsuke Matsumoto; Mayumi Sako; Kazushi Tsuruga; Koichi Nakanishi; Koichi Kamei; Hiroshi Saito; Shuichiro Fujinaga; Yuko Hamasaki; Hiroko Chikamoto; Kenji Ishikura; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2015-02       Impact factor: 2.801

6.  Pulmonary thrombosis as the first manifestation of systemic lupus erythematosus in a 14-year-old boy.

Authors:  Annie Harroche; Natascha Remus; Solenn Gaubicher; Olivier Dunand; Magali Colombat; Christophe Delacourt; Fouad Madhi
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

7.  Increased pulmonary arterial pressure in children with nephrotic syndrome.

Authors:  Z-D Du; L Cao; L Liang; D Chen; Z-Z Li
Journal:  Arch Dis Child       Date:  2004-09       Impact factor: 3.791

8.  Pulmonary embolism revealing idiopathic membranous glomerulonephritis.

Authors:  A Hamzaoui; O Harzallah; R Klii; L Njim; S Mahjoub
Journal:  Case Rep Med       Date:  2010-09-20

9.  Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience.

Authors:  Betul Tavil; Fehime Kara; Rezan Topaloglu; Selin Aytac; Sule Unal; Baris Kuskonmaz; Mualla Cetin; Nesrin Besbas; Fatma Gumruk
Journal:  Clin Exp Nephrol       Date:  2014-07-04       Impact factor: 2.801

10.  Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.

Authors:  Asiri S Abeyagunawardena; Peter Hindmarsh; Richard S Trompeter
Journal:  Arch Dis Child       Date:  2007-02-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.